Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

SHA:688050 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	680.1	363.9	536.66	354.9	472.87	536.84
Short-Term Investments	-	-	-	-	480	450
Trading Asset Securities	6.62	132.27	20.12	481.97	0.48	0.28
Cash & Short-Term Investments	686.72	496.17	556.78	836.86	953.35	987.12
Cash Growth	46.34%	-10.89%	-33.47%	-12.22%	-3.42%	402.79%
Accounts Receivable	498.46	353.15	212.82	103.52	67.8	74.22
Other Receivables	11.09	5.34	6.03	3.71	6.57	4.69
Receivables	509.55	358.49	218.85	107.23	74.37	78.91
Inventory	334.06	272.63	181.35	78.83	56.02	59.07
Prepaid Expenses	-	-	-	-	0.15	1
Other Current Assets	56.79	53.34	65.89	38.36	34.83	20.08
Total Current Assets	1,587	1,181	1,023	1,061	1,119	1,146
Property, Plant & Equipment	1,453	1,503	1,257	674.21	558.69	267.13
Long-Term Investments	163.41	207.83	157.44	153.56	102.16	40.78
Goodwill	190.86	139.11	132.6	21.13	21.13	-
Other Intangible Assets	214.47	190.43	174.21	107.04	91.39	90.92
Long-Term Deferred Tax Assets	79.33	72.89	46.74	29.91	34.35	25.12
Long-Term Deferred Charges	159.74	149.56	105.72	60.83	67.49	49.57
Other Long-Term Assets	54.79	36.85	149.43	120.81	45.49	18.83
Total Assets	3,903	3,497	3,062	2,244	2,048	1,639
Accounts Payable	65.31	56.08	49.05	13.86	5.57	2.18
Accrued Expenses	44.62	55.74	50.87	42.59	31.82	17.97
Short-Term Debt	-	-	25.55	-	-	-
Current Portion of Long-Term Debt	174.03	80.83	92.39	-	-	-
Current Portion of Leases	-	4.71	-	-	-	-
Current Income Taxes Payable	23.42	3.77	2.31	13.5	6.99	4.1
Current Unearned Revenue	6.9	11.46	12.6	6.47	6.16	3.41
Other Current Liabilities	67.64	86.32	145	71.29	88.88	49.43
Total Current Liabilities	381.92	298.91	377.77	147.71	139.42	77.09
Long-Term Debt	438.55	513.13	287.44	149.77	143.37	-
Long-Term Leases	26.64	10.23	13.85	13.02	11.48	-
Long-Term Unearned Revenue	31.65	22.35	10.53	8.9	10.76	12.62
Long-Term Deferred Tax Liabilities	14.94	16.26	15.14	4.26	0.8	-
Other Long-Term Liabilities	1.26	1.82	1.13	0.64	1.63	1.18
Total Liabilities	894.96	862.71	705.85	324.3	307.46	90.89
Common Stock	193.4	189.54	105.25	105.18	105.14	105.14
Additional Paid-In Capital	1,370	1,197	1,325	1,311	1,318	1,305
Retained Earnings	1,264	1,037	699.81	444.01	250.23	107.74
Treasury Stock	-20.04	-20.04	-	-	-	-
Comprehensive Income & Other	3.31	6.33	-	-	-	-
Total Common Equity	2,811	2,409	2,130	1,860	1,674	1,518
Minority Interest	197.52	224.76	226.3	59.96	66.29	29.53
Shareholders' Equity	3,008	2,634	2,356	1,920	1,740	1,548
Total Liabilities & Equity	3,903	3,497	3,062	2,244	2,048	1,639
Total Debt	639.21	608.9	419.23	162.79	154.85	-
Net Cash (Debt)	47.51	-112.73	137.55	674.07	798.5	987.12
Net Cash Growth	-	-	-79.59%	-15.58%	-19.11%	402.79%
Net Cash Per Share	0.25	-0.60	0.72	3.56	4.22	6.13
Filing Date Shares Outstanding	193.4	189.54	189.45	189.32	189.25	189.25
Total Common Shares Outstanding	193.4	189.54	189.45	189.32	189.25	189.25
Working Capital	1,205	881.72	645.1	913.59	979.3	1,069
Book Value Per Share	14.53	12.71	11.24	9.83	8.84	8.02
Tangible Book Value	2,405	2,080	1,823	1,732	1,561	1,427
Tangible Book Value Per Share	12.44	10.97	9.62	9.15	8.25	7.54
Buildings	-	879.35	676.61	414.46	150.37	136.27
Machinery	-	874.05	618.13	232.76	155.95	102.28
Construction In Progress	-	52.88	154.26	120.6	318.44	81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.